Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikes | PNAS
“We demonstrated the efficacy of the peptide against various mutant spike proteins and authentic SARS-CoV-2 variants and confirmed its tolerance to existing and potential future mutations.”
We demonstrated the efficacy of the peptide against various mutant spike proteins and authentic SARS-CoV-2 variants and confirmed its tolerance to existing and potential future mutations.
Japanese researchers develop peptide preventing COVID-19 infections
"The peptide comprises 39 natural amino acids, and it is inexpensive and easily synthesized," Institute of Science Tokyo Distinguished Professor Yoshinori Fujiyoshi said. "It only binds to spike proteins, so it can be considered to have no side effects."